NOCIL Limited Commences Trial Batches at Dahej Facility for Rubber Chemicals Capacity Enhancement
NOCIL Limited has commenced trial batches at its Dahej facility for rubber chemicals capacity enhancement, following its Rs 250 crore capital expenditure announcement from 26th March, 2024. The company will send samples to customers for approval after trial runs and will separately announce commercial production commencement. This development marks a significant milestone in NOCIL's expansion strategy for its rubber chemicals business segment.

*this image is generated using AI for illustrative purposes only.
NOCIL Limited has reached a significant milestone in its capacity enhancement project at the Dahej facility, announcing the commencement of trial batches for rubber chemicals production. The company made this disclosure on 3rd April, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Project Background and Investment
The trial batch commencement follows NOCIL's earlier announcement dated 26th March, 2024, regarding its substantial investment in capacity enhancement. The company had disclosed capital expenditure not exceeding Rs 250 crore specifically allocated towards expanding rubber chemicals production capacity at its Dahej facility.
| Project Parameter: | Details |
|---|---|
| Investment Amount: | Not exceeding Rs 250 crore |
| Facility Location: | Dahej |
| Product Focus: | Rubber Chemicals |
| Project Type: | Capacity Enhancement |
| Announcement Date: | 26th March, 2024 |
Current Development Status
The company has successfully initiated trial batches at the facility, marking a crucial phase in the project timeline. According to the official communication, the trial process involves multiple stages designed to ensure product quality and customer satisfaction.
The operational framework includes:
- Conducting comprehensive trial runs
- Sample preparation and quality assessment
- Customer sample distribution for approval
- Evaluation and feedback collection
Next Phase and Commercial Production
NOCIL has indicated that following the trial runs, samples will be sent to customers for approval processes. This customer validation phase represents a critical step before full-scale commercial operations can commence. The company has committed to providing separate intimation regarding the commencement of commercial production once the trial phase concludes successfully.
Strategic Significance
This capacity enhancement project at Dahej represents NOCIL's continued focus on expanding its rubber chemicals business. The substantial investment of up to Rs 250 crore demonstrates the company's commitment to strengthening its market position and meeting growing demand in the rubber chemicals sector. The successful initiation of trial batches indicates progress toward achieving the project's operational objectives.
Historical Stock Returns for NOCIL
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.87% | +3.14% | +14.27% | -5.08% | -6.95% | -8.46% |
What timeline is NOCIL targeting for customer approvals and the transition to full commercial production at the Dahej facility?
How will the additional capacity from this Rs 250 crore investment impact NOCIL's market share in the competitive rubber chemicals sector?
Could NOCIL consider similar capacity enhancement projects at other facilities if the Dahej expansion proves successful?


































